Login / Signup
In ASCVD, an inclisiran-first strategy reduced LDL-C levels and statin discontinuation at 330 d.
Ellis Lader
Published in:
Annals of internal medicine (2024)
J Am Coll Cardiol. 2024;83:1939-1952. 38593947.
Keyphrases
</>
low density lipoprotein
cardiovascular disease
coronary artery disease